| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| car-20/19-t cells | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] T-Lymphocyte[MeSHID:D013601] Pancreatic carcinoma[MeSHID:C562463] Chronic Lymphocytic Leukemia[MeSHID:D015451] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| car-20/19-t cells | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of pancreas[MeSHID:D010190] T-Lymphocyte[MeSHID:D013601] Pancreatic carcinoma[MeSHID:C562463] Chronic Lymphocytic Leukemia[MeSHID:D015451] B-Cell Lymphomas[MeSHID:D016393] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||